Gastrointestinal System
Gastrointestinal
High-yield gastroenterology for USMLE Step 2/3 — esophageal pathology, malabsorption, IBD, liver disease, pancreatitis, GI bleeding, and infectious diarrhea, extracted from Divine Intervention and organized by organ system for exam performance.
Esophagus & Upper GI
Esophageal pathology on the USMLE is built around a simple framework: dysphagia to solids only (mechanical) vs solids and liquids (motility), and the GERD → Barrett's → adenocarcinoma progression. Mastering the bird's beak, the gastrographin swallow, and the distinction between achalasia (increased LES tone) and scleroderma (decreased LES tone) unlocks the majority of esophageal questions on Step 2 and Step 3.
EP489
The Clutch Esophagus Podcast
- Esophageal perforation: After EGD / instrumentation → sudden fever, severe chest pain, pneumomediastinum, subcutaneous emphysema (crepitus). Diagnose with gastrographin (water-soluble contrast) swallow — never barium. Boerhaave syndrome = transmural spontaneous rupture (bulimics/anorexics who retch violently)
- Achalasia: Dysphagia to solids AND liquids + regurgitation of undigested food. Loss of myenteric plexus ganglion cells (nitric oxide neurons degenerate) → increased LES tone. Bird's beak on barium swallow → esophageal manometry → EGD (to rule out cancer)
- Achalasia causes: Idiopathic (most common) vs. Chagas disease (Trypanosoma cruzi, South American) vs. pseudoachalasia from esophageal malignancy compressing outside
- Scleroderma esophagus: CREST — the E stands for esophageal dysmotility. Fibrosis causes decreased LES tone (vs. achalasia = increased). Leads to severe GERD → Barrett's → strictures → adenocarcinoma
- Achalasia treatment: Botox injection (temporary, ~6 months), pneumatic dilation (risk = esophageal perforation → gastrographin enema), surgical Heller myotomy (most durable)
- Pill esophagitis: Doxycycline, bisphosphonates, potassium — can cause esophageal ulceration and rarely rupture if stuck
Achalasia vs Scleroderma — The Key Comparison
| Feature | Achalasia | Scleroderma |
|---|---|---|
| LES tone | Increased (cannot relax) | Decreased (incompetent) |
| Dysphagia type | Solids AND liquids from onset | Solids first → progresses |
| Key finding | Bird's beak on barium; aperistalsis | GERD dominant; fibrotic strictures later |
| Mechanism | Loss of nitric oxide neurons in Auerbach's plexus | Smooth muscle fibrosis → incompetence |
| Cancer risk | Squamous cell carcinoma (stasis) | Adenocarcinoma via Barrett's |
| South America clue | Trypanosoma cruzi → Chagas → achalasia | Not applicable |
Critical — Never Use Barium if Perforation Suspected
Barium in the mediastinum causes severe mediastinitis. If esophageal perforation is suspected (after dilation, instrumentation, or violent vomiting), always order water-soluble contrast (gastrographin). Signs of perforation: subcutaneous emphysema, widened mediastinum on CXR, pneumomediastinum, severe pleuritic chest pain + fever.
Achalasia Workup — Step by Step
- Step 1: Barium swallow → bird's beak (tapering of distal esophagus)
- Step 2: Esophageal manometry → confirms aperistalsis + high LES pressure
- Step 3: EGD (upper endoscopy) → rule out pseudoachalasia from cancer
Pneumatic Dilation Complication
After pneumatic dilation for achalasia → patient becomes hypotensive, febrile, has subcutaneous emphysema = esophageal perforation. Next step: gastrographin swallow (water-soluble contrast). Do NOT order barium swallow.
Esophageal Perforation — Boerhaave vs Mallory-Weiss
| Condition | Tear Depth | Trigger | Key Finding | Management |
|---|---|---|---|---|
| Mallory-Weiss | Mucosal only | Violent vomiting (alcohol binge) | Hematemesis, hemodynamically stable | Usually self-limiting; EGD |
| Boerhaave | Transmural | Forceful vomiting (bulimia/anorexia) | Pneumomediastinum, Rice Krispie crepitus, fever 105°F | Emergency surgery (celiotomy) + broad-spectrum abx |
EP295
Esophageal Cancer, Dysphagia Differential, and Esophagitis
- Esophageal adenocarcinoma: Most common in the US. Risk factor = Barrett's esophagus (not just GERD — use the pathway rule: pick the closest step). Located in the lower 1/3. Lymph node drainage = celiac/gastric nodes
- Esophageal squamous cell carcinoma: Most common worldwide. Risk factors = smoking, alcohol, achalasia, caustic ingestion (lye/bleach), hot food, Plummer-Vincent syndrome. Located in the upper 2/3
- Candida esophagitis: Immunocompromised (HIV, transplant). White plaques. Treat with fluconazole (oral or lozenge form). First-line in dysphagia + HIV = Candida (don't wait for biopsy)
- HSV esophagitis: Punched-out ulcers. CD4 <100. Treat with acyclovir. Biopsy: multinucleated giant cells
- CMV esophagitis: Linear ulcers. Post-transplant or CD4 <50. Treat with ganciclovir. Resistance to ganciclovir = UL97 kinase mutation → use foscarnet (pyrophosphate analog, pre-activated)
- Esophageal strictures: From caustic ingestion (within months), chronic GERD, or Crohn's disease healing — dysphagia to solids, progressive
Esophageal Cancer — Two Types Side by Side
| Feature | Adenocarcinoma | Squamous Cell Carcinoma |
|---|---|---|
| Location | Lower 1/3 (GEJ area) | Upper 2/3 |
| US prevalence | Most common in US | Most common worldwide |
| Key risk factor | Barrett's esophagus (GERD → metaplasia) | Smoking, alcohol, achalasia, caustic injury, hot food |
| Pathway rule | If asked "biggest risk factor" and both GERD and Barrett's are choices → pick Barrett's (closer in pathway) | Any esophageal insult except GERD/Barrett's = SCC |
| Plummer-Vincent | No | Yes — iron deficiency + esophageal webs + glossitis → SCC risk |
Pathway Rule — USMLE Test Strategy
GERD → Barrett's esophagus → esophageal adenocarcinoma. If the question asks "what is the biggest risk factor for esophageal adenocarcinoma?" and both GERD and Barrett's are answer choices, pick Barrett's esophagus — it is the closest pathophysiological step to the outcome.
Esophagitis in Immunocompromised Patients
| Pathogen | CD4 Level | Biopsy Finding | Presentation Clue | Treatment |
|---|---|---|---|---|
| Candida albicans | Any immunosuppressed | Pseudohyphae (KOH prep) | White plaques; first-line guess without biopsy | Fluconazole (oral or lozenge) |
| HSV | <100 | Multinucleated giant cells; punched-out ulcers | Prior cold sores; punched-out lesions | Acyclovir |
| CMV | <50 | Owl's eye inclusions; linear ulcers | Post-transplant; linear not punched-out | Ganciclovir → foscarnet if resistant |
Ganciclovir Resistance Mechanism
Ganciclovir requires activation by UL97 kinase. If CMV develops a UL97 kinase mutation, ganciclovir cannot be activated. Switch to foscarnet (pyrophosphate analog — does not require kinase activation, works directly on DNA polymerase).
EP294
GERD, Barrett's Esophagus, PPIs & H2 Blockers
- GERD mechanism: Decreased lower esophageal sphincter (LES) tone → acid reflux. Risk: obesity, alcohol, smoking, caffeine, hiatal hernia. Symptom: chest pain worse lying down, nocturnal cough
- GERD management: PPI first-line (most powerful acid reducer). If fails → increase PPI dose → if still fails → EGD. Alarm symptoms (weight loss, age >50, chronic GERD >10 years) → skip to EGD immediately. Gold standard: 24-hour pH monitoring
- Barrett's esophagus: Metaplasia from stratified squamous → columnar with goblet cells (intestinal epithelium). Occurs due to chronic acid exposure. Seen as salmon-pink mucosa on EGD. Increases risk of esophageal adenocarcinoma
- PPI mechanism: Irreversibly inhibit H+/K+ ATPase on parietal cells. Used for GERD, Zollinger-Ellison, H. pylori triple therapy (CAP: Clarithromycin + Amoxicillin + PPI). Complication: ↑ aspiration pneumonia risk (↓ gastric acidity)
- Cimetidine HY facts: H2 blocker; strong CYP450 inhibitor → raises levels of co-administered drugs; causes gynecomastia; also used for acute intermittent porphyria (inhibits ALA synthase) and dermatitis herpetiformis adjunct
- Stress ulcer prophylaxis: Curling's ulcer (burns) and Cushing's ulcer (increased ICP/brain injury) → both prevented with PPI. Chronic steroids → also give PPI prophylaxis
GERD Management Algorithm
- Initial symptoms → start PPI (lifestyle changes: weight loss, stop smoking/alcohol/caffeine)
- PPI fails × 6 weeks → increase to maximum PPI dose
- Still fails → EGD (esophagogastroduodenoscopy)
- Alarm symptoms (weight loss, age >50, GERD >10 years, dysphagia) → go straight to EGD
- EGD normal → 24-hour esophageal pH monitoring (gold standard for GERD diagnosis)
- Surgical option: Nissen fundoplication
Barrett's Esophagus — The Histology
Normal esophageal epithelium = stratified squamous non-keratinized. Barrett's = metaplasia to intestinal epithelium (non-ciliated columnar cells with goblet cells). Goblet cells are the key. This is a response to chronic acid damage. Risk: esophageal adenocarcinoma. Surveillance: EGD with biopsy every 3–5 years.
H2 Blockers — Cimetidine Special Properties
| Property | Clinical Implication |
|---|---|
| CYP450 inhibitor | Raises blood levels of warfarin, phenytoin, theophylline — watch for toxicity |
| Gynecomastia | Anti-androgenic effect → breast tissue growth in males |
| Acute intermittent porphyria | Inhibits ALA synthase (rate-limiting enzyme in heme synthesis) → reduces porphyrin intermediates |
| Dermatitis herpetiformis adjunct | Can help alongside dapsone in patients with celiac-associated rash |
Stress Ulcers — Curling's vs Cushing's
| Ulcer Name | Cause | Mechanism | Prevention |
|---|---|---|---|
| Curling's | Severe burn injury | Splanchnic vasoconstriction → gastric mucosal ischemia | PPI prophylaxis |
| Cushing's | Increased ICP (stroke, meningitis, TBI) | ↑ ICP → vagal tone → ↑ gastrin-releasing peptide → ↑ acid | PPI prophylaxis |
Also: chronic steroid therapy → always place on PPI prophylaxis (steroids increase PUD risk) AND bisphosphonate (steroids inhibit osteoblasts → osteoporosis).
EP298
Schatzky's Ring, Plummer-Vincent Syndrome & Esophageal Varices
- Schatzky's ring: Extra mucosal tissue forming a complete circle at the squamocolumnar junction → intermittent dysphagia to solids. EGD shows well-demarcated ring. Diagnose: barium swallow → EGD. Treat: esophageal dilation (risk = perforation)
- Plummer-Vincent syndrome: Triad = iron deficiency anemia + esophageal webs + glossitis (smooth tongue). Webs do NOT form a complete circle (vs. Schatzky's ring). Risk of esophageal squamous cell carcinoma. Clue: microcytic anemia + dysphagia in middle-aged woman
- Esophageal varices: Portal hypertension (cirrhosis/alcoholism) → submucosal vessel dilation → rupture → massive hematemesis. Sign: asterixis (hepatic flapping tremor), ascites (fluid wave)
- Varices management: IV fluid + blood first. Then: IV octreotide (↓ portal pressure) + IV PPI + EGD with banding or sclerotherapy + IV antibiotic (ceftriaxone or fluoroquinolone, ↓ SBP risk). Refractory → TIPS procedure (portosystemic shunt) → risk: hyperammonemia → give lactulose
- Varices prophylaxis: Non-selective beta-blocker (propranolol) + spironolactone → splanchnic vasoconstriction → ↓ portal pressure → ↓ re-bleed risk
Schatzky's Ring vs Plummer-Vincent — Key Differentiation
| Feature | Schatzky's Ring | Plummer-Vincent Syndrome |
|---|---|---|
| Tissue formation | Completes full circle at squamocolumnar junction | Incomplete — does not encircle mucosa (web) |
| Anemia | Not typically associated | Iron deficiency anemia (mandatory part of triad) |
| Tongue | Normal | Glossitis, smooth tongue |
| Cancer risk | Low | Squamous cell carcinoma |
| Dysphagia type | Intermittent to solids | Progressive to solids |
Esophageal Varices — Management Priority Order
1. Two large-bore peripheral IVs → 2. Normal saline (fluids first, blood second) → 3. Blood if Hgb <7 or hemodynamically unstable → 4. IV octreotide + IV PPI → 5. EGD with banding or sclerotherapy + IV antibiotics → 6. If refractory: TIPS procedure. After discharge: propranolol + spironolactone for re-bleed prophylaxis.
TIPS — Mechanism and Complication
Mechanism: Transjugular intrahepatic portosystemic shunt — connects portal vein to hepatic vein, bypassing the liver. Performed by interventional radiology.
Complication: Bypasses the liver's urea cycle → ammonia accumulates → hepatic encephalopathy. Give lactulose (converted to lactic acid → acidifies ammonia to ammonium → excreted in stool) and rifaximin prophylactically.
RR 118EP575
Scleroderma & the Esophagus: Strictures, Barrett's, and Pregnancy GERD
- Scleroderma + dysphagia: CREST (Calcinosis, Raynaud's, Esophageal dysmotility, Sclerodactyly, Telangiectasias). Fibrosis → incompetent LES → severe GERD → esophageal strictures → next step: EGD. Can progress to Barrett's → adenocarcinoma
- USMLE twist: Scleroderma + dysphagia to solids + weight loss → think esophageal stricture (not just dysmotility) or esophageal adenocarcinoma. Get EGD, not just manage GERD empirically
- Pregnancy GERD: Progesterone = powerful smooth muscle relaxant → relaxes LES → GERD. Worsens as pregnancy progresses, resolves after delivery (placenta out). Treatment: PPI is safe in pregnancy
- Scleroderma "new schema": USMLEs test classic diseases in unusual populations — Barrett's can occur in scleroderma patients, not just obese/alcoholic men. Any cause of chronic LES incompetence → Barrett's risk
Scleroderma GI Complications
- Incompetent LES → severe GERD → Barrett's → esophageal adenocarcinoma
- Esophageal strictures from chronic GERD healing with fibrosis → dysphagia to solids
- Small bowel dysmotility → bacterial overgrowth → diarrhea and malabsorption
- EGD next step when scleroderma patient has OTC-refractory dysphagia
Progesterone and the GI Tract
Progesterone relaxes smooth muscle throughout the body. GI effects: ↓ LES tone (GERD), ↓ ureteral tone (urinary stasis → UTI risk), ↓ systemic vascular resistance (↓ BP in pregnancy). This explains why GERD worsens as placenta grows (more progesterone) and resolves postpartum.
Small Bowel, Malabsorption & Inflammatory Bowel Disease
IBD mastery comes from contrast — Crohn's is transmural (fistulas, strictures, skip lesions, terminal ileum always involved, B12 deficiency, oxalate stones) while UC is mucosal (rectum always involved, bloody diarrhea, tenesmus, PSC association). Celiac targets duodenum/jejunum, spares ileum; Crohn's hits the terminal ileum. Knowing the mechanism of diarrhea (osmotic vs secretory vs inflammatory vs motility) transforms what looks like guessing into systematic reasoning.
EP293
GI Anatomy, Embryology & Mesenteric Ischemia
- GI blood supply: Celiac trunk = foregut (esophagus, stomach, liver, duodenum). Superior mesenteric artery (SMA) = midgut (distal duodenum → proximal 2/3 transverse colon). Inferior mesenteric artery (IMA) = hindgut (distal transverse colon → rectum)
- Acute mesenteric ischemia: Sudden severe abdominal pain + peritonitis signs in patient with AFib or recent MI. Most commonly: SMA occlusion (embolus from left atrium or left ventricle). Distinguish by acute onset (not weeks)
- C. diff colitis: After antibiotic therapy → watery diarrhea + abdominal pain. Toxic megacolon involves the transverse colon (colon dilation seen on plain film). Diagnose: stool toxin PCR
- Abdominal wall layers: Skin → Camper's fascia → Scarpa's fascia → External oblique → Internal oblique → Transversus abdominis → Transversalis fascia → Extraperitoneal fascia → Parietal peritoneum → Visceral peritoneum
GI Blood Supply — Foregut / Midgut / Hindgut
| Division | Extent | Blood Supply | Key Structures |
|---|---|---|---|
| Foregut | Mouth → ligament of Treitz (proximal duodenum) | Celiac trunk | Esophagus, stomach, liver, gallbladder, pancreas, proximal duodenum |
| Midgut | Distal duodenum → proximal 2/3 transverse colon | Superior mesenteric artery (SMA) | Small intestine, cecum, appendix, ascending colon, proximal transverse colon |
| Hindgut | Distal 1/3 transverse colon → rectum | Inferior mesenteric artery (IMA) | Descending colon, sigmoid, rectum |
Acute Mesenteric Ischemia — Classic Presentation
AFib or recent MI → embolus → SMA occlusion → sudden severe abdominal pain out of proportion to exam (pain severe but abdomen may be soft initially). CT angiography for diagnosis. Distinguish from chronic mesenteric ischemia ("intestinal angina" — postprandial pain, weight loss, atherosclerosis) by the abrupt onset.
EP294
Celiac Disease — Pathophysiology, Biopsy, and Dermatitis Herpetiformis
- Celiac disease: Malabsorption + floating malodorous stools + low body weight + skin rash (dermatitis herpetiformis). Symptoms improve with gluten withdrawal. No physical exam abnormalities ↔ lactase deficiency (which has no exam findings or lab abnormalities)
- Celiac intestinal involvement: Duodenum and jejunum primarily. Spares the ileum (vs. Crohn's which always involves terminal ileum). This explains why celiac → B12 deficiency is uncommon; Crohn's → B12 deficiency is classic
- Celiac biopsy: Villous atrophy + intraepithelial lymphocytosis (buzzword). T-cell mediated damage (similar mechanism to minimal change disease — T cells damage epithelium). HLA-DQ2 and HLA-DQ8 genetic susceptibility
- Celiac antibodies: IgA anti-tissue transglutaminase (most important), IgA anti-gliadin, anti-endomysial antibodies. HLA: DQ2 and DQ8
- Celiac complications: EATL (enteropathy-associated T-cell lymphoma) — rare but high-yield. Also iron/folate deficiency from duodenal malabsorption
- Dermatitis herpetiformis: Pruritic papulovesicular rash on extensor surfaces (elbows, knees). Treat with dapsone (also used for PCP prophylaxis and leprosy)
Celiac vs Crohn's — Intestinal Distribution
| Feature | Celiac Disease | Crohn's Disease |
|---|---|---|
| Primarily affects | Duodenum and jejunum | Terminal ileum (always) + any segment mouth-to-anus |
| Spares | Ileum (typically) | Rectum (typically) |
| B12 deficiency | Uncommon (ileum intact) | Classic (terminal ileum = B12 absorption site) |
| Oxalate kidney stones | No | Yes — increased colonic oxalate reabsorption |
| Trigger | Gluten | Unknown (immune-mediated) |
| Biopsy hallmark | Villous atrophy + intraepithelial lymphocytosis | Non-caseating granulomas (transmural) |
Celiac Pathophysiology — Step by Step
Tissue transglutaminase converts ingested gluten → gliadin → APC with HLA-DQ2/DQ8 presents gliadin to T cells → T cell activation → T cells destroy intestinal villi → villous atrophy. This is T-cell (not antibody) mediated damage. Compare to minimal change disease (also T-cell mediated podocyte damage).
Dapsone Uses on NBME Exams
- Dermatitis herpetiformis (celiac-associated rash)
- PCP (Pneumocystis jirovecii) prophylaxis — when TMP-SMX is contraindicated
- Leprosy (24 months: dapsone + rifampin + clofazimine)
- Mechanism: competitive inhibitor of dihydropteroate synthetase (same as sulfonamides) → blocks folate synthesis in bacteria
EP384
IBDs and the USMLEs — Crohn's vs Ulcerative Colitis
- Crohn's disease: Terminal ileum always involved. Transmural inflammation → fistulas (enterocutaneous, enterovesical → fecaluria/pneumaturia), strictures, skip lesions, non-caseating granulomas on biopsy. Watery diarrhea (not typically bloody). Complication: B12 deficiency, oxalate nephrolithiasis
- Ulcerative colitis: Rectum always involved. Mucosal/submucosal only → no fistulas. Continuous lesions (no skip). Bloody diarrhea + tenesmus. Associated: primary sclerosing cholangitis (PSC), p-ANCA positive
- Fecal calprotectin: Screening test for IBD — positive whenever neutrophils are in GI tract. Very sensitive. Negative = rules out IBD. Positive → proceed to colonoscopy (cannot distinguish UC from Crohn's without biopsy)
- Anemia of IBD: Anemia of chronic disease (NOT iron deficiency) — ferritin elevated, TIBC low, transferrin saturation low. Hepcidin blocks iron reabsorption. Treat with IV iron (not oral — hepcidin blocks GI absorption)
- Treatment: Flares → steroids (never for maintenance). UC maintenance: mesalazine. Crohn's: TNF inhibitors (infliximab), antibiotics. Cure UC: proctocolectomy. Crohn's: surgery for strictures/fistulas only (resection does not cure — recurs at anastomosis)
- Microscopic colitis: Watery diarrhea + normal colonoscopy grossly. Biopsy: lymphocytic colitis (lymphocytes only) or collagenous colitis (lymphocytes + sub-epithelial collagen band). Treat with budesonide
Crohn's vs UC — The Complete Comparison
| Feature | Crohn's Disease | Ulcerative Colitis |
|---|---|---|
| Location | Any segment mouth to anus; terminal ileum always | Colon only; rectum always involved |
| Depth | Transmural (all layers) | Mucosal/submucosal only |
| Pattern | Skip lesions | Continuous lesion |
| Biopsy | Non-caseating granulomas | Crypt abscesses, no granulomas |
| Diarrhea type | Watery (non-bloody typically) | Bloody + tenesmus |
| Fistulas | Yes (transmural) | No |
| Strictures | Yes | No (on NBME exams) |
| B12 deficiency | Yes (terminal ileum) | No |
| Oxalate stones | Yes (↑ colonic oxalate absorption) | No |
| Biliary disease | No (no PSC) | Yes — PSC (p-ANCA positive) |
| Surgery | Does not cure | Proctocolectomy = curative |
| Serology | ASCA (anti-Saccharomyces) | p-ANCA |
Colovesical Fistula — Pathognomonic for Crohn's
Crohn's can form a fistula between colon and bladder. Classic presentation: fecaluria (feces in urine) or pneumaturia (air bubbles in urine). On NBME exams, fistulas of any kind → Crohn's. Strictures → Crohn's. Both are consequences of transmural inflammation.
IBD Anemia — Why IV Iron, Not Oral
IBD = chronic inflammation → ↑ hepcidin → hepcidin blocks ferroportin in enterocytes AND in bone marrow macrophages → iron sequestered, not released. Oral iron is absorbed via gut enterocytes, but hepcidin blocks ferroportin so iron can't exit the enterocytes into blood. IV iron bypasses the gut entirely → effective. Do NOT give oral iron in IBD-related anemia of chronic disease.
Colorectal Cancer Screening in IBD
- IBD alone (UC or Crohn's) → start surveillance colonoscopy 8–10 years after diagnosis, then every 1–2 years
- PSC alone → start colonoscopy at time of PSC diagnosis, then every 5 years
- PSC + IBD → start colonoscopy at time of PSC diagnosis, then every 1–2 years (highest risk)
EP512
Mechanisms of Diarrhea — Osmotic, Secretory, Inflammatory, Motility
- Osmotic diarrhea: Poorly absorbed solute stays in GI lumen → holds water osmotically. Causes: lactose intolerance (lactase deficiency = brush border enzyme), magnesium antacids, sugar-free candy (sorbitol). Key: diarrhea stops with fasting or eliminating the offending food
- Secretory diarrhea: Toxin-driven hypersecretion of chloride into lumen → water follows. Cholera toxin: activates adenylyl cyclase → ↑ cAMP → opens Cl⁻ channels. ETEC: heat-labile toxin (↑ cAMP), heat-stable toxin (↑ cGMP). VIPoma: WDHA syndrome (watery diarrhea, hypokalemia, achlorhydria). Key: diarrhea persists despite fasting
- Inflammatory/infectious diarrhea: Mucosal barrier disruption by pathogens or IBD → blood/serum leaks into lumen, ↓ reabsorption. Causes: Salmonella, Campylobacter jejuni, E. coli O157:H7, Shigella, Rotavirus (kids), Norovirus (cruise ships)
- Motility diarrhea: Too fast (hypermotility → inadequate absorption time) or too slow (bacterial overgrowth from stasis → fermentation + diarrhea). Scleroderma, diabetes gastroparesis, anticholinergic drugs cause stasis → overgrowth
- Oral rehydration therapy: Salt + sugar solution activates SGLT1 (sodium-glucose linked transporter in gut) → sodium reabsorption pulls water. This is the mechanism behind WHO ORT for cholera
Diarrhea Mechanisms — Master Table
| Type | Mechanism | Classic Causes | Key Differentiator |
|---|---|---|---|
| Osmotic | Unabsorbed solute draws water into lumen | Lactase deficiency, Mg antacids, sorbitol, celiac disease, pancreatic insufficiency | Stops with fasting / eliminating offending substance |
| Secretory | Toxin → ↑ cAMP/cGMP → ↑ Cl⁻ secretion → water follows | Cholera (adenylyl cyclase), ETEC, VIPoma, laxatives, caffeine | Persists despite fasting; large volume, watery |
| Inflammatory/Infectious | Mucosal barrier damaged → exudate + impaired reabsorption | Shigella, Salmonella, Campylobacter, IBD, C. diff, rotavirus | Often bloody; fever; inflammatory markers elevated |
| Motility — Too fast | Transit time too short → inadequate absorption | Hyperthyroidism, dumping syndrome, post-gastrectomy | No specific lab finding; correlates with gut speed |
| Motility — Too slow | Stasis → bacterial overgrowth → fermentation + toxins | Scleroderma, diabetic gastroparesis, blind loop syndrome | B12 deficiency (bacteria consume B12) |
Cholera Toxin Mechanism (HY for Step 1 in Step 2/3)
Cholera toxin → ADP-ribosylates Gs protein (permanent activation) → adenylyl cyclase continuously active → ↑ cAMP → PKA phosphorylates CFTR → massive Cl⁻ secretion into gut lumen → water follows osmotically → rice-water stool. Treatment: aggressive ORT (salt-sugar solution activates SGLT1 to pump Na+ and water back in).
VIPoma — WDHA Syndrome
Watery Diarrhea + Hypokalemia + Achlorhydria. VIP (vasoactive intestinal peptide) stimulates adenylyl cyclase in gut → ↑ cAMP → secretory diarrhea. Also inhibits gastric acid (achlorhydria). Treat: octreotide. Locate tumor: CT/MRI pancreas (usually pancreatic neuroendocrine tumor).
EP318
Menetrier's Disease, Transudative Effusions & Pancreatitis
- Menetrier's disease: Protein-losing gastropathy ("nephrotic syndrome of the stomach"). Massive hypertrophied gastric folds with cerebriform (brain-like) appearance on EGD. Low serum albumin → anasarca + transudative effusions. Treat: high-protein diet; severe cases → cetuximab or gastrectomy
- LIGHTS criteria (transudative effusions): All three must be met — (1) pleural fluid protein / serum protein <0.5; (2) pleural fluid LDH / serum LDH <0.6; (3) pleural fluid LDH <2/3 upper limit of normal serum LDH. Transudative causes: low oncotic pressure (hypoalbuminemia, Menetrier's, nephrotic syndrome, cirrhosis) or high hydrostatic pressure (CHF, constrictive pericarditis)
- Blind loop syndrome: After gastric bypass or Billroth procedures → segment of bowel bypassed/denervated → stasis → bacterial overgrowth → B12 deficiency (bacteria consume B12) + fat-soluble vitamin deficiency + diarrhea
Transudative vs Exudative Effusions — Mechanisms
| Mechanism | Type | Classic Causes |
|---|---|---|
| ↓ Oncotic pressure (low albumin) | Transudative | Cirrhosis, nephrotic syndrome, Menetrier's, malnutrition, hypothyroidism |
| ↑ Hydrostatic pressure | Transudative | CHF, constrictive pericarditis, SVC obstruction |
| ↑ Capillary permeability (inflammation) | Exudative | Pneumonia, malignancy, PE, TB, autoimmune, pancreatitis |
Menetrier's Disease vs Hypertrophic Pyloric Stenosis
Menetrier's = hypertrophied gastric folds in adults, protein-losing. Hypertrophic pyloric stenosis = thickened pylorus in infants 2–6 weeks old, projectile non-bilious vomiting, palpable olive mass, hypochloremic hypokalemic metabolic alkalosis. These are easy to mix up; age and EGD vs ultrasound findings distinguish them.
RR 62EP334
C. diff Colitis, IBD, and Antibiotic-Associated Diarrhea
- C. diff colitis: After antibiotic therapy → watery diarrhea. Diagnosis: stool C. diff toxin PCR. Pathogen uses toxins (toxin A and B) to cause colitis. Treatment: oral vancomycin (first-line) or oral fidaxomicin (NBME-tested alternative). Do NOT give IV vancomycin — must be oral
- C. diff antibiotic-associated mechanism: Antibiotics (especially clindamycin, fluoroquinolones, cephalosporins) disrupt normal flora → C. diff overgrowth → toxin release → secretory + inflammatory diarrhea. Toxin detected in stool = diagnostic
- Toxic megacolon: Complication of UC or C. diff. Severe abdominal pain + distension + fever + hemodynamic instability. Plain film X-ray → transverse colon dilation >6 cm. Contraindications: barium enema and colonoscopy (risk bowel perforation). Conservative management → surgery if peritonitis or perforation
C. diff Treatment — Key NBME Points
- First episode: oral vancomycin OR oral fidaxomicin (fidaxomicin is increasingly favored on newer exams)
- Recurrent: fecal microbiota transplant (FMT) is emerging but oral vancomycin still preferred on Step 2/3
- Oral vancomycin ONLY — IV vancomycin does not reach colon, wrong answer every time
- Diagnosis: stool toxin PCR (most sensitive and specific)
Toxic Megacolon — What NOT to Do
Toxic megacolon (complication of UC or C. diff): do NOT do barium enema (can perforate) and do NOT do colonoscopy (same risk). Order plain abdominal X-ray first — transverse colon >6 cm = toxic megacolon. If peritonitis develops → emergency colectomy (subtotal colectomy).
RR 63EP335
Gastroparesis, GI Motility & Bacterial Overgrowth
- GI motility and bacterial overgrowth: Stasis from scleroderma, diabetic gastroparesis, or anticholinergic drugs → bacteria proliferate in small bowel → fermentation → bloating, flatulence, diarrhea, B12 deficiency (bacteria consume B12 before ileum can absorb it)
- Dumping syndrome: Post-gastrectomy → unregulated food flow from stomach to small bowel → osmotic fluid shift → diarrhea + nausea immediately after eating. Treat: small frequent meals, avoid simple carbohydrates
- Diabetic gastroparesis: Autonomic neuropathy in chronic diabetes → delayed gastric emptying → nausea/vomiting after meals, early satiety. Diagnose: gastric emptying scintigraphy (nuclear medicine). Treat: metoclopramide (promotility) or erythromycin (motilin agonist)
GI Motility Disorders — Stasis Consequences
- Too slow → bacteria don't move → overgrowth at 100× normal density → fermentation → bloating, diarrhea, B12 deficiency
- Too fast → food exits stomach before being absorbed → osmotic diarrhea (dumping syndrome) or malabsorption
- Scleroderma: fibrosis of GI smooth muscle → stasis anywhere from esophagus to colon
- Diabetic neuropathy: autonomous degeneration → gastroparesis + small bowel dysmotility → overgrowth
Dumping Syndrome — Early vs Late
Early dumping (30 min post-meal): Osmotic shift of fluid from blood into gut lumen → hypovolemia + diarrhea. Late dumping (2–3 hrs post-meal): Rapid glucose absorption → hyperinsulinemia → reactive hypoglycemia. Both treated with small frequent meals and avoiding simple sugars. Octreotide for severe cases.
RR 81EP408
GI Infections, Bacterial Pathogens & Dumping Syndrome
- Post-gastrectomy dumping syndrome: Unregulated passage of food from remnant stomach into small bowel → osmotic diarrhea + nausea/hypoglycemia. Treat: small frequent meals, avoid carbohydrates; severe cases: octreotide
- Ascending cholangitis (GI context): Stone occludes common bile duct + infection → fever + right upper quadrant pain + jaundice (Charcot's triad). If hypotension + altered mental status added = Reynolds pentad (septic). Treat with ERCP + IV antibiotics (ampicillin + gentamicin + metronidazole)
- Differentiate cholangitis from cholecystitis: Cholecystitis = fever + RUQ pain, NO jaundice (cystic duct blocked, CBD intact). Cholangitis = fever + RUQ + JAUNDICE (CBD blocked). Choledocholithiasis = RUQ + jaundice, NO fever
- Inflammatory cytokines and GI: IL-1, IL-6, TNF-alpha = pyrogens → post-surgical fever within hours. Cortisol post-surgery = demargination of neutrophils → leukocytosis. Normal surgical response, not infection
Cholecystitis vs Choledocholithiasis vs Ascending Cholangitis
| Condition | Fever | RUQ Pain | Jaundice | Blocked Duct | Management |
|---|---|---|---|---|---|
| Cholecystitis | Yes | Yes | No | Cystic duct | Laparoscopic cholecystectomy |
| Choledocholithiasis | No | Yes | Yes | Common bile duct | ERCP to remove stone |
| Ascending cholangitis | Yes (high) | Yes | Yes | Common bile duct + infection | ERCP + IV abx (amp+gent+metro) |
| Reynolds pentad | Yes | Yes | Yes | CBD + sepsis | Emergent ERCP + ICU |
RR 117EP553
IBD Prognosis, Toxic Megacolon & Colorectal Cancer Surveillance
- Toxic megacolon workup: UC patient with severe abdominal pain + distension + high fever → plain abdominal X-ray first. Transverse colon >6 cm = toxic megacolon. Contraindicated: barium enema and colonoscopy (perforation risk)
- IBD and colorectal cancer risk: IBD → CRC diagnosed at younger age, more aggressive (higher grade), multifocal lesions throughout colon. Sporadic CRC → older age, usually polyp-derived, localized. IBD-related CRC does NOT typically arise from polyps — flat dysplastic lesions instead
- Colonoscopy surveillance: IBD alone → 8–10 years after diagnosis, every 1–2 years. PSC alone → at time of diagnosis, every 5 years. PSC + IBD → at time of PSC diagnosis, every 1–2 years (most aggressive surveillance)
- Cirrhosis biopsy finding: Diffuse fibrosis + nodular architecture outlined by fibrosis. Non-alcoholic fatty liver disease (metabolism-associated liver disease) is a common cause — ALT > AST, associated with metabolic syndrome, obesity, diabetes
IBD-Related Colorectal Cancer — Prognosis Facts
| Feature | IBD-Related CRC | Sporadic CRC |
|---|---|---|
| Age at diagnosis | Younger | Older (>50) |
| Grade / aggressiveness | Higher grade, more aggressive | Variable |
| Origin | Flat dysplastic mucosa (NOT polyps) | Usually from adenomatous polyps |
| Distribution | Multifocal throughout colon | Localized, single lesion |
Toxic Megacolon — Triggers and Contraindications
Causes: UC (most common), C. diff, less commonly Crohn's or other infectious colitis. Do NOT perform barium enema or colonoscopy (both can rupture the colon). Order plain abdominal film first. Management: NPO + IV fluids + broad-spectrum antibiotics. If fails or peritonitis develops: emergency subtotal colectomy.
RR 118EP575
HUS from Shigella — Schistocytes, MAHA & E. coli Distinction
- HUS triad: Microangiopathic hemolytic anemia (MAHA) + thrombocytopenia + acute renal failure. Bloody diarrhea → HUS in a child. Most common cause: E. coli O157:H7 (EHEC, not ETEC). If EHEC not an answer choice → Shigella is second
- E. coli distinction (HY): ETEC (enterotoxigenic) = traveler's diarrhea, does NOT cause HUS. EHEC (enterohemorrhagic, O157:H7) = DOES cause HUS. If exam lists "enterotoxigenic E. coli" — it does NOT cause HUS; pick Shigella instead
- HUS pathogenesis: Shiga toxin (from Shigella or EHEC) → invades intestinal mucosa → bloody diarrhea → toxin enters bloodstream → damages renal microvasculature → MAHA + thrombocytopenia + AKI
- HUS management: Supportive care ONLY. DO NOT give antibiotics — killing bacteria releases more Shiga toxin → worsens AKI. No antibiotics in HUS
- Blood smear: Schistocytes (fragmented erythrocytes) = hallmark of MAHA. Also seen in DIC, TTP. Platelet count low but PT/aPTT normal (unlike DIC)
HUS vs TTP — Critical Distinction
| Feature | HUS | TTP |
|---|---|---|
| Classic trigger | E. coli O157:H7 or Shigella (children) | ADAMTS13 deficiency (adults, women) |
| Renal failure | Prominent (AKI) | Mild |
| Neurologic symptoms | Absent | Prominent (confusion, seizures) |
| Blood smear | Schistocytes | Schistocytes |
| Platelets | Low | Very low |
| PT/aPTT | Normal (unlike DIC) | Normal (unlike DIC) |
| Treatment | Supportive care only; NO antibiotics | Plasma exchange (plasmapheresis) |
Never Give Antibiotics in HUS
Antibiotics in EHEC/Shigella HUS → lyse bacteria → mass release of Shiga toxin → worsened endothelial damage → worsened AKI. This is the opposite of most GI infections. Supportive care only: fluids, transfusion if needed, dialysis if severe AKI.